Table 2.
Other diagnoses associated with ICD-10-CM diagnosis code Z77.120: “Contact with and (suspected) exposure to mold (toxic)” — United States, April 1, 2016–April 1, 2022
| Commercial (n=10,761) | Medicaid (n=7,944) | |||||||
|---|---|---|---|---|---|---|---|---|
| Condition1,2 | n | % | aOR3 | (95% CI) | n | % | aOR4 | (95% CI) |
| Acute upper respiratory infection | 1,128 | 10.5% | 2.09 | (1.96–2.22) | 1,526 | 19.2% | 2.94 | (2.77–3.12) |
| Acute sinusitis | 1,264 | 11.7% | 2.29 | (2.16–2.43) | 766 | 9.6% | 2.74 | (2.54–2.97) |
| Allergic contact dermatitis | 119 | 1.1% | 1.82 | (1.52–2.19) | 86 | 1.1% | 1.95 | (1.56–2.44) |
| Allergic rhinitis | 3,224 | 30.0% | 6.82 | (6.55–7.11) | 2,668 | 33.6% | 6.82 | (6.49–7.17) |
| Anxiety disorder | 2,304 | 21.4% | 3.66 | (3.50–3.84) | 1,467 | 18.5% | 3.20 | (3.00–3.41) |
| Atopic dermatitis | 204 | 1.9% | 2.54 | (2.21–2.92) | 365 | 4.6% | 3.00 | (2.68–3.35) |
| Asthma | 1,891 | 17.6% | 5.26 | (5.00–5.52) | 1,852 | 23.3% | 3.87 | (3.67–4.09) |
| Chronic obstructive pulmonary disease (COPD) or other chronic lower respiratory disease | 737 | 6.8% | 3.08 | (2.85–3.32) | 591 | 7.4% | 2.77 | (2.52–3.05) |
| Chronic sinusitis | 1,156 | 10.7% | 6.96 | (6.55–7.40) | 481 | 6.1% | 5.24 | (4.75–5.77) |
| Conjunctivitis | 479 | 4.5% | 2.01 | (1.83–2.20) | 508 | 6.4% | 2.19 | (2.00–2.41) |
| Depression | 1,336 | 12.4% | 2.75 | (2.59–2.91) | 993 | 12.5% | 2.08 | (1.93–2.23) |
| Diabetes | 621 | 5.8% | 0.80 | (0.74–0.87) | 345 | 4.3% | 1.06 | (0.94–1.20) |
| Fibromyalgia | 366 | 3.4% | 6.74 | (6.07–7.49) | 247 | 3.1% | 6.20 | (5.41–7.11) |
| Food allergy | 273 | 2.5% | 7.20 | (6.38–8.13) | 224 | 2.8% | 4.97 | (4.31–5.73) |
| Fungal infection | ||||||||
| Aspergillosis, invasive | 2 | 0.0% | 16.20 | (4.07–64.41) | 3 | 0.0% | 35.06 | (11.10–110.72) |
| Aspergillosis, non-invasive or unspecified | 69 | 0.6% | 123.30 | (96.36–157.80) | 16 | 0.2% | 54.12 | (31.60–92.67) |
| Dermatophytosis | 294 | 2.7% | 1.32 | (1.17–1.48) | 215 | 2.7% | 1.59 | (1.38–1.84) |
| Mucormycosis | 4 | 0.0% | 118.01 | (43.32–321.51) | 0 | 0.0% | 0.01 | (<0.01–999.99) |
| Unspecified mycosis | 70 | 0.7% | 37.03 | (28.96–47.35) | 12 | 0.2% | 8.33 | (4.47–15.53) |
| Vulvovaginal candidiasis | 145 | 1.3% | 2.35 | (2.00–2.77) | 112 | 1.4% | 1.54 | (1.26–1.88) |
| Hypersensitivity pneumonitis | 44 | 0.4% | 73.83 | (54.64–99.76) | 25 | 0.3% | 89.48 | (58.88–135.97) |
| Hypertension | 1,755 | 16.3% | 0.90 | (0.85–0.96) | 898 | 11.3% | 1.43 | (1.31–1.56) |
| Hypothyroidism | 1,431 | 13.3% | 2.54 | (2.39–2.69) | 365 | 4.6% | 2.69 | (2.40–3.02) |
| Lyme disease | 574 | 5.3% | 55.42 | (50.91–60.34) | 52 | 0.7% | 41.06 | (30.91–54.53) |
| Smoking (current or past) | 695 | 6.5% | 1.99 | (1.84–2.15) | 1,133 | 14.3% | 1.73 | (1.61–1.86) |
| Pneumonia | 342 | 3.2% | 3.34 | (3.00–3.72) | 267 | 3.4% | 2.74 | (2.39–3.08) |
| Vitamin D deficiency | 1,423 | 13.2% | 2.77 | (2.62–2.94) | 468 | 5.9% | 2.92 | (2.64–3.24) |
1
Non-mutually exclusive categories
2
In the 90 days before through 90 days after the Z77.120 diagnosis code was first used during the study period
3
Adjusting for age and sex
4
Adjusting for age, sex, and race/ethnicity